ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
TAMOXIFEN CITRATE: products 1 to 8 of 8.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Tamox 10mg TabDIN 00812404 | General benefit | $0.1750per source unit | Requirements & sourcesBuild cost plan |
| Apo-Tamox 20mg TabDIN 00812390 | General benefit | $0.3500per source unit | Requirements & sourcesBuild cost plan |
| Nolvadex 10mg TabDIN 02048477 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Nolvadex D 20mg TabDIN 02048485 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Tamofen 10mg TabDIN 01926624 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Tamofen 20mg TabDIN 01926632 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Teva-Tamoxifen 10mg TabDIN 00851965 | General benefit | $0.1750per source unit | Requirements & sourcesBuild cost plan |
| Teva-Tamoxifen 20mg TabDIN 00851973 | General benefit | $0.3500per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.